|
|
||||||||
attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model

,1
* Department of Internal Medicine, Research Center for Allergic Immune Diseases, Chonbuk National University Medical School, Jeonju, South Korea; and
ICOS Corporation, Bothell, Washington, USA
1Correspondence: K.D.P., ICOS Corporation, 22021 20th Ave. SE, Bothell, WA 98021, USA. E-mail: kpuri{at}icos.com or Y.C.L., Department of Internal Medicine, Chonbuk National University Medical School, 634-18, Keumamdong, Jeonju, 561-712, South Korea. E-mail: leeyc{at}chonbuk.ac.kr
P110
phosphoinositide 3-kinase (PI3K) plays a pivotal role in the recruitment and activation of certain inflammatory cells. Recent findings revealed that the activity of p110
also contributes to allergen-IgE-induced mast cell activation and vascular permeability. We investigated the role of p110
in allergic airway inflammation and hyperresponsiveness using IC87114, a selective p110
inhibitor, in a mouse asthma model. BALB/c mice were sensitized with OVA and, upon OVA aerosol challenge, developed airway eosinophilia, mucus hypersecretion, elevation in cytokine and chemokine levels, up-regulation of ICAM-1 and VCAM-1 expression, and airway hyperresponsiveness. Intratracheal administration of IC87114 significantly (P<0.05) attenuated OVA-induced influx into lungs of total leukocytes, eosinophils, neutrophils, and lymphocytes, as well as levels of IL-4, IL-5, IL-13, and RANTES in a dose-dependent manner. IC87114 also significantly (P<0.05) reduced the serum levels of total IgE and OVA-specific IgE and LTC4 release into the airspace. Histological studies show that IC87114 inhibited OVA-induced lung tissue eosinophilia, airway mucus production, and inflammation score. In addition, IC87114 significantly (P<0.05) suppressed OVA-induced airway hyperresponsiveness to inhaled methacholine. Western blot analyses of whole lung tissue lysates shows that IC87114 markedly attenuated the OVA-induced increase in expression of IL-4, IL-5, IL-13, ICAM-1, VCAM-1, RANTES, and eotaxin. Furthermore, IC87114 treatment markedly attenuated OVA-induced serine phosphorylation of Akt, a downstream effector of PI3K signaling. Taken together, our findings implicate that inhibition of p110
signaling pathway may have therapeutic potential for the treatment of allergic airway inflammation.Lee, K. S., Lee, H. K., Hayflick, J. S., Lee, Y. C., Puri, K. D. Inhibition of phosphoinositide 3-kinase
attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model.
Key Words: allergy inflammation cell activation lung cytokines signal transduction
This article has been cited by other articles:
![]() |
C.-W. Lee, C.-C. Lin, S.-F. Luo, H.-C. Lee, I.-T. Lee, W. C. Aird, T.-L. Hwang, and C.-M. Yang Tumor Necrosis Factor-{alpha} Enhances Neutrophil Adhesiveness: Induction of Vascular Cell Adhesion Molecule-1 via Activation of Akt and CaM Kinase II and Modifications of Histone Acetyltransferase and Histone Deacetylase 4 in Human Tracheal Smooth Muscle Cells Mol. Pharmacol., May 1, 2008; 73(5): 1454 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. M. Farghaly, I. S. Blagbrough, D. A. Medina-Tato, and M. L. Watson Interleukin 13 Increases Contractility of Murine Tracheal Smooth Muscle by a Phosphoinositide 3-kinase p110{delta}-Dependent Mechanism Mol. Pharmacol., May 1, 2008; 73(5): 1530 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Kim, H. S. Kuehn, D. D. Metcalfe, and A. M. Gilfillan Activation and Function of the mTORC1 Pathway in Mast Cells J. Immunol., April 1, 2008; 180(7): 4586 - 4595. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohta, M. Hayashi, T. Kanemaru, K. Abe, Y. Ito, and M. Oike Dual Modulation of Airway Smooth Muscle Contraction by Th2 Cytokines via Matrix Metalloproteinase-1 Production J. Immunol., March 15, 2008; 180(6): 4191 - 4199. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ali, M. Camps, W. P. Pearce, H. Ji, T. Ruckle, N. Kuehn, C. Pasquali, C. Chabert, C. Rommel, and B. Vanhaesebroeck Isoform-Specific Functions of Phosphoinositide 3-Kinases: p110{delta} but Not p110{gamma} Promotes Optimal Allergic Responses In Vivo J. Immunol., February 15, 2008; 180(4): 2538 - 2544. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-a. Moon, S. Y. Kim, T.-B. Kim, E. S. Yun, C.-S. Park, Y. S. Cho, H.-B. Moon, and K.-Y. Lee Allergen-induced CD11b+ CD11cint CCR3+ macrophages in the lung promote eosinophilic airway inflammation in a mouse asthma model Int. Immunol., December 1, 2007; 19(12): 1371 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Kim, K. S. Lee, S. J. Park, K. H. Min, K. Y. Lee, Y. H. Choe, Y. R. Lee, J. S. Kim, S. J. Hong, and Y. C. Lee PTEN Down-Regulates IL-17 Expression in a Murine Model of Toluene Diisocyanate-Induced Airway Disease J. Immunol., November 15, 2007; 179(10): 6820 - 6829. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kim, A. Saudemont, L. Webb, M. Camps, T. Ruckle, E. Hirsch, M. Turner, and F. Colucci The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion Blood, November 1, 2007; 110(9): 3202 - 3208. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ito, G. Caramori, and I. M. Adcock Therapeutic Potential of Phosphatidylinositol 3-Kinase Inhibitors in Inflammatory Respiratory Disease J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 1 - 8. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |